Literature DB >> 6984320

Radioimmunoassay for metabolites of 9,3"-diacetylmidecamycin, a macrolide antibiotic.

N Shimada, T Ueda, T Yokoshima, K Umemura, T Shomura.   

Abstract

A radioimmunoassay system has been developed for the measurement of two major metabolites of 9,3"-diacetylmidecamycin, Mb-6 and Mb-12. A radioimmunoassay for Mb-6 was performed by using anti-Mb-6 serum and a [125I]tyramined Mb-6 derivative as a radiolabeled antigen. The labeled antigen was prepared by the chloramine T method. The antiserum was obtained from a rabbit immunized with Mb-6 conjugated to bovine serum albumin. The obtained antiserum was cross-reactive with two other metabolites of 9,3"-diacetylmidecamycin, Mb-2 and Mb-12, in addition to Mb-6. This Mb-6 radioimmunoassay system could detect Mb-6 concentrations as low as 100 pg/ml of serum. The coefficients of variation were 4.5% (intra-assay) and 5.1% (inter-assay). A radioimmunoassay for Mb-12, using anti-midecamycin serum and a [125I]tyramined-Mb-12 derivative, has also been developed. The antiserum was cross-reactive only with Mb-12 among the 9,3"-diacetylmidecamycin metabolites. This Mb-12 radioimmunoassay system could detect Mb-12 concentrations as low as 2 ng/ml. The intra- and inter-assay variances were 5.9 and 5.8%, respectively.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6984320      PMCID: PMC185704          DOI: 10.1128/AAC.22.6.976

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Studies on absorption, distribution, metabolism and excretion of a new macrolide antibiotic SF-837. I. Absorption, metabolism and excretion of SF-837.

Authors:  T Shomura; K Umemura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1973-08       Impact factor: 1.645

3.  [Metabolism of 9,3"-diacetylmidecamycin. I. The metabolic fate of 9,3"-diacetylmidecamycin].

Authors:  T Shomura; S Someya; K Umemura; M Nishio; S Murata
Journal:  Yakugaku Zasshi       Date:  1982-08       Impact factor: 0.302

4.  Metabolism of 9,3"-diacetylmidecamycin. II. The structures of several metabolites of 9,3"-diacetylmidecamycin.

Authors:  T Shomura; S Someya; S Murata; K Umemura; M Nishi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-09       Impact factor: 1.645

5.  Modifications of a macrolide antibiotic midecamycin (SF-837). I. Synthesis and structure of 9,3''-diacetylmidecamycin.

Authors:  S Omoto; K Iwamatsu; S Inouye; T Niida
Journal:  J Antibiot (Tokyo)       Date:  1976-05       Impact factor: 2.649

  5 in total
  1 in total

1.  Enzyme immunoassay for macrolide antibiotics: characterization of an antibody to 23-amino-O-mycaminosyltylonolide.

Authors:  R C Yao; D F Mahoney
Journal:  Appl Environ Microbiol       Date:  1989-06       Impact factor: 4.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.